AHRQ: Treating cardiovascular disease costs U.S. hospitals nearly $60B

Treating heart attack victims, opening clogged arteries and treating other common cardiovascular conditions cost U.S. hospitals $57.9 billion in 2006, about 40 percent more than in 1997, according to new data from the Agency for Healthcare Research and Quality (AHRQ).

In its latest News and Numbers report, the agency revealed that most of the growth in costs occurred between 1997 and 2003. Since 2003, annual growth in costs for these conditions has slowed to less than 2 percent—attributable to a slight decline in the number of heart disease cases and slower increases in the cost per case.

The AHRQ said that the analysis, which adjusted cost figures for inflation, showed how much U.S. hospital costs increased between 1997 and 2006 for:
  • Hospital treatment of patients with coronary artery disease increased from $14.5 billion in 1997 to $17.5 billion in 2006 (a 2.1 percent annual increase);
  • Costs for treating patients with heart attacks increased from $9 billion to $11.8 billion (a 3 percent annual increase);
  • Costs for treating patients with congestive heart failure increased from $6.6 billion to $11.2 billion (a 6.1 percent annual increase);
  • Costs for treating patients with irregular heart beats increased from $3.5 billion to $6.8 billion (a 7.7 percent annual increase);
  • Costs for treating patients with stroke increased from $5.3 billion to $6.7 billion (a 2.6 percent annual increase);
  • Costs for treating patients with chest pain with no determined cause increased from $1.6 billion to $3.9 billion. The condition increased more than any other of these heart-related conditions – increasing by about 10 percent annually from 1997 to 2006.
Treatment for these conditions accounted for 17.6 percent of the $329 billion hospitals spent on patient care in 2006—slightly lower than in 1997 when the conditions accounted for 18.7 percent of the $216 billion spent.

The AHRQ News and Numbers summary is based on data in HCUP Facts and Figures, 2006, which highlights data from the 2006 Nationwide Inpatient Sample, a part of AHRQ's Healthcare Cost and Utilization Project.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.